Clinical Trial Update: Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial of HR091506 tablets for gout with hyperuricemia in adults that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• HR091506 tablets (HR091506)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gout With Hyperuricemia in Adults | Phase 3 | Status: NOT_YET_RECRUITING